Emergency medication / VISN 2 / syracuse VAMC / FY21 / Q1

Ended Awarded

Contract number
36C24221N0229
Awardee
Awarding agency
Obligated
$22,969

Award facts

Contract value 100% obligated
$22,969.02 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Earth City, MO 63045, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the supply of emergency medication to the Department of Veterans Affairs (VA) Syracuse Medical Center, specifically for the Veterans Integrated Service Network (VISN) 2 region. The contract was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products. Takeda Pharmaceuticals America is a subsidiary of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, based in Japan.

The contract, valued at $22,969.02, is a Blanket Purchase Agreement (BPA) call under Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. This single-award BPA, valued at over $13 million, was originally awarded to Takeda in October 2019 and is set to run through October 2024. The contract is for firm-fixed-price deliveries of specialty medication, such as the oncology drugs ICLUSIG (ponatinib) and NINLARO (ixazomib), to various VA medical facilities across the country. This contract does not have a set-aside designation.

Quick answers

Who was awarded contract 36C24221N0229?

36C24221N0229 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 2 (Veterans Health Administration) on October 13, 2020.

How much is contract 36C24221N0229 worth?

The government has obligated $22,969 on 36C24221N0229.

Is contract 36C24221N0229 an order under another contract?

Yes. 36C24221N0229 is a BPA call under 36F79718D0586-36E79720A0001, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24221N0229 competed?

The extent of competition for 36C24221N0229 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award